Tiansheng Pharmaceutical Group Co

Tiansheng Pharmaceutical Group Co DSCR

The Debt Service Coverage Ratio (DSCR) of Tiansheng Pharmaceutical Group Co (002872.SZ) as of Oct 26, 2026 is 0.31. In the previous year, Debt Service Coverage Ratio (DSCR) was 0.18 — a change of 73.20% (higher).

DSCR

0.31

YoY

73.20%

Last updated:

Debt Service Coverage Ratio (DSCR) of Tiansheng Pharmaceutical Group Co is 2025 0.31 . Debt Service Coverage Ratio (DSCR) of Tiansheng Pharmaceutical Group Co was 2024 0.18 . It decreases by 73.20% higher compared to the previous year.

The Tiansheng Pharmaceutical Group Co DSCR history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

DSCR
Date
DSCR
Jan 1, 2018
0.22 CNY
Jan 1, 2019
0.23 CNY
Jan 1, 2020
0.38 CNY
Jan 1, 2021
0.05 CNY
Jan 1, 2022
0.33 CNY
Jan 1, 2023
-0.14 CNY
Jan 1, 2024
0.18 CNY
Jan 1, 2025
0.31 CNY
The Tiansheng Pharmaceutical Group Co DSCR history
YEARDSCRYoY
0.31+73.20%
0.18-229.98%
-0.14-141.78%
0.33+516.39%
0.05-85.91%
0.38+66.25%
0.23+3.24%
0.22-438.19%
-0.07-108.69%
0.76+109.06%
0.36-9.52%
0.40—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Tiansheng Pharmaceutical Group Co Stock analysis

What does Tiansheng Pharmaceutical Group Co do? Tiansheng Pharmaceutical Group Co., Ltd. generates revenue through the manufacturing and distribution of pharmaceutical products primarily within the domestic market. Its main products include pediatric lung cough particles, erythromycin enteric-coated capsules, silver ginseng Tongluo capsules, Salvia granules, Shugan Yi spleen granules, compound Ganoderma lucidum granules, Xiangdan injection, Qi and Diabetes tablets, liver capsule, Ling Jing capsule, lungs of nuclear paste, and Shen Qi Yi lung pill. The company focuses on domestic sales, targeting consumers seeking traditional Chinese medicine solutions for respiratory and digestive health. The firm's product portfolio emphasizes traditional Chinese medicine formulations, with specific offerings like Shugan Yi spleen granules for digestive issues and Ling Jing capsule for respiratory conditions. These products are distributed through domestic channels, catering to a market segment that prefers herbal remedies over conventional pharmaceuticals. Tiansheng's revenue stream is derived from the sale of these branded pharmaceutical items to pharmacies and healthcare providers within China. Tiansheng Pharmaceutical Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tiansheng Pharmaceutical Group Co stock

Debt Service Coverage Ratio (DSCR) of Tiansheng Pharmaceutical Group Co is 0.31 in 2025.

Debt Service Coverage Ratio (DSCR) of Tiansheng Pharmaceutical Group Co changed from 0.18 to 0.31, representing a 73.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Service Coverage Ratio (DSCR) Tiansheng Pharmaceutical Group Co since 2006 – with annual values, charts, and detailed analysis.

The DSCR measures a company's ability to service its debt obligations from operating income. A ratio above 1.0 indicates sufficient income to cover debt payments.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt Service Coverage Ratio (DSCR)'s Tiansheng Pharmaceutical Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Tiansheng Pharmaceutical Group Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Tiansheng Pharmaceutical Group Co